| 3.1 |
9.3 |
GO:2000830 |
vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 2.5 |
9.9 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) |
| 1.6 |
4.7 |
GO:0060279 |
regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 1.4 |
1.4 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 1.4 |
6.8 |
GO:0009440 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 1.3 |
3.9 |
GO:0090427 |
activation of meiosis(GO:0090427) |
| 1.3 |
6.3 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 1.2 |
7.5 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 1.2 |
1.2 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 1.2 |
8.1 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 1.1 |
3.4 |
GO:1901207 |
regulation of heart looping(GO:1901207) |
| 1.1 |
4.4 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 1.1 |
6.5 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 1.1 |
3.2 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 1.0 |
4.1 |
GO:0045013 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.0 |
9.8 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 1.0 |
2.9 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 1.0 |
5.8 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.9 |
4.6 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.9 |
0.9 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) |
| 0.9 |
0.9 |
GO:0045601 |
regulation of endothelial cell differentiation(GO:0045601) positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.9 |
3.6 |
GO:1904482 |
response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.9 |
4.4 |
GO:2000110 |
negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.9 |
0.9 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.9 |
3.4 |
GO:0039020 |
pronephric nephron tubule development(GO:0039020) |
| 0.8 |
2.5 |
GO:0046081 |
dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.8 |
2.5 |
GO:0034226 |
lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
| 0.8 |
1.6 |
GO:0019521 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.8 |
4.9 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.8 |
4.0 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.8 |
3.2 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.8 |
0.8 |
GO:0071874 |
response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.8 |
2.4 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 0.8 |
3.2 |
GO:0014859 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.8 |
1.5 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.8 |
3.1 |
GO:0032811 |
regulation of epinephrine secretion(GO:0014060) negative regulation of epinephrine secretion(GO:0032811) epinephrine secretion(GO:0048242) |
| 0.8 |
1.5 |
GO:2000437 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.7 |
4.4 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.7 |
2.9 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.7 |
5.1 |
GO:2000542 |
negative regulation of gastrulation(GO:2000542) |
| 0.7 |
0.7 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.7 |
2.2 |
GO:1902356 |
thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 0.7 |
1.4 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.7 |
2.1 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 0.7 |
7.7 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.7 |
2.8 |
GO:0072287 |
metanephric distal tubule morphogenesis(GO:0072287) |
| 0.7 |
2.0 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 0.7 |
2.0 |
GO:0097187 |
dentinogenesis(GO:0097187) |
| 0.7 |
0.7 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.7 |
2.7 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.7 |
3.3 |
GO:0019242 |
methylglyoxal biosynthetic process(GO:0019242) |
| 0.7 |
1.3 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.7 |
4.0 |
GO:0015887 |
biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.7 |
0.7 |
GO:0060214 |
endocardium formation(GO:0060214) |
| 0.7 |
2.0 |
GO:0031548 |
regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.7 |
2.0 |
GO:0061110 |
dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.7 |
2.0 |
GO:0032203 |
telomere formation via telomerase(GO:0032203) |
| 0.7 |
2.6 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.6 |
1.9 |
GO:0050760 |
negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.6 |
3.2 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.6 |
3.2 |
GO:1903412 |
response to bile acid(GO:1903412) |
| 0.6 |
5.1 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.6 |
6.4 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.6 |
5.0 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.6 |
8.7 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.6 |
4.3 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.6 |
5.6 |
GO:0046618 |
drug export(GO:0046618) |
| 0.6 |
2.4 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 0.6 |
1.8 |
GO:0070902 |
mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.6 |
2.4 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.6 |
1.8 |
GO:0071922 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.6 |
4.6 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.6 |
0.6 |
GO:1901860 |
positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.6 |
7.4 |
GO:0043435 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.6 |
6.8 |
GO:0071321 |
cellular response to cGMP(GO:0071321) |
| 0.6 |
0.6 |
GO:0051660 |
establishment of centrosome localization(GO:0051660) |
| 0.6 |
2.8 |
GO:0071409 |
cellular response to cycloheximide(GO:0071409) |
| 0.5 |
2.7 |
GO:0034653 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.5 |
1.6 |
GO:0061181 |
regulation of chondrocyte development(GO:0061181) |
| 0.5 |
9.2 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.5 |
1.6 |
GO:0003168 |
Purkinje myocyte differentiation(GO:0003168) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 0.5 |
2.7 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.5 |
1.6 |
GO:0009443 |
pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.5 |
6.8 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.5 |
4.2 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 0.5 |
1.6 |
GO:0042660 |
positive regulation of cell fate specification(GO:0042660) |
| 0.5 |
1.6 |
GO:0061743 |
motor learning(GO:0061743) maintenance of synapse structure(GO:0099558) |
| 0.5 |
2.1 |
GO:0071393 |
cellular response to progesterone stimulus(GO:0071393) |
| 0.5 |
1.5 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.5 |
1.5 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.5 |
3.5 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.5 |
4.5 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.5 |
4.0 |
GO:0070649 |
polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 0.5 |
3.0 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.5 |
3.0 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.5 |
0.5 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 0.5 |
1.5 |
GO:0051086 |
chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 0.5 |
2.9 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.5 |
2.4 |
GO:1904845 |
response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 0.5 |
2.9 |
GO:0051673 |
membrane disruption in other organism(GO:0051673) |
| 0.5 |
1.4 |
GO:1902990 |
mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.5 |
1.9 |
GO:0000915 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.5 |
2.4 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.5 |
2.4 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.5 |
0.5 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.5 |
0.5 |
GO:0021538 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.5 |
1.8 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 0.5 |
1.4 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) molecular hydrogen transport(GO:0015993) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.5 |
9.1 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.5 |
0.9 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.4 |
2.2 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.4 |
12.1 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.4 |
1.8 |
GO:1903721 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.4 |
1.3 |
GO:0034164 |
negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.4 |
1.3 |
GO:1902203 |
negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
| 0.4 |
4.4 |
GO:0010912 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.4 |
1.7 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.4 |
1.3 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.4 |
1.3 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.4 |
0.4 |
GO:0061549 |
sympathetic ganglion development(GO:0061549) |
| 0.4 |
3.4 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.4 |
4.3 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.4 |
0.8 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.4 |
1.3 |
GO:0006173 |
dADP biosynthetic process(GO:0006173) |
| 0.4 |
1.7 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.4 |
2.5 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.4 |
1.2 |
GO:0042727 |
flavin-containing compound biosynthetic process(GO:0042727) |
| 0.4 |
1.6 |
GO:0060168 |
positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.4 |
0.8 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.4 |
1.6 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.4 |
1.6 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.4 |
2.8 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.4 |
5.2 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.4 |
1.2 |
GO:0060722 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.4 |
1.6 |
GO:0009189 |
deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
| 0.4 |
2.7 |
GO:0030200 |
proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.4 |
1.9 |
GO:0071733 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.4 |
5.0 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.4 |
1.1 |
GO:0014707 |
branchiomeric skeletal muscle development(GO:0014707) |
| 0.4 |
1.1 |
GO:0043105 |
regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.4 |
1.1 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
| 0.4 |
1.5 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.4 |
1.5 |
GO:0034499 |
late endosome to Golgi transport(GO:0034499) |
| 0.4 |
1.5 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.4 |
1.1 |
GO:0033091 |
positive regulation of immature T cell proliferation(GO:0033091) |
| 0.4 |
0.7 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.4 |
2.6 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.4 |
0.7 |
GO:1900157 |
regulation of bone mineralization involved in bone maturation(GO:1900157) |
| 0.4 |
0.7 |
GO:0010767 |
regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 0.4 |
1.1 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.4 |
0.7 |
GO:0033081 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.4 |
1.5 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.4 |
2.9 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.4 |
1.1 |
GO:0052151 |
positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.4 |
1.1 |
GO:0036333 |
hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.4 |
2.1 |
GO:2001153 |
regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.4 |
2.5 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.4 |
0.4 |
GO:1904378 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.4 |
1.1 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.4 |
2.1 |
GO:0035407 |
histone H3-T11 phosphorylation(GO:0035407) |
| 0.4 |
3.2 |
GO:0021840 |
directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.4 |
1.1 |
GO:1903217 |
regulation of protein processing involved in protein targeting to mitochondrion(GO:1903216) negative regulation of protein processing involved in protein targeting to mitochondrion(GO:1903217) |
| 0.3 |
1.4 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 0.3 |
1.7 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 0.3 |
2.1 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.3 |
1.4 |
GO:1904398 |
positive regulation of neuromuscular junction development(GO:1904398) |
| 0.3 |
4.5 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.3 |
0.3 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.3 |
0.3 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.3 |
1.0 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.3 |
0.3 |
GO:0038108 |
negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.3 |
1.0 |
GO:1904975 |
response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.3 |
1.0 |
GO:0021938 |
ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 0.3 |
0.7 |
GO:0098881 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.3 |
1.7 |
GO:0010310 |
regulation of hydrogen peroxide metabolic process(GO:0010310) |
| 0.3 |
0.7 |
GO:0036148 |
phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.3 |
0.7 |
GO:0005997 |
xylulose metabolic process(GO:0005997) |
| 0.3 |
0.7 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.3 |
0.3 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.3 |
0.7 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.3 |
1.0 |
GO:1901079 |
positive regulation of relaxation of muscle(GO:1901079) |
| 0.3 |
0.7 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 0.3 |
13.4 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.3 |
0.7 |
GO:0014038 |
regulation of Schwann cell differentiation(GO:0014038) |
| 0.3 |
1.6 |
GO:0019464 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.3 |
1.3 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.3 |
1.3 |
GO:0046035 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.3 |
1.9 |
GO:1904048 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 0.3 |
1.0 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.3 |
3.5 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.3 |
1.9 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.3 |
0.3 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.3 |
2.5 |
GO:0090116 |
C-5 methylation of cytosine(GO:0090116) |
| 0.3 |
0.6 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.3 |
5.0 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.3 |
1.2 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.3 |
0.9 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.3 |
1.2 |
GO:0006535 |
cysteine biosynthetic process from serine(GO:0006535) |
| 0.3 |
0.9 |
GO:0098502 |
DNA dephosphorylation(GO:0098502) |
| 0.3 |
0.9 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.3 |
0.9 |
GO:0061154 |
endothelial tube morphogenesis(GO:0061154) |
| 0.3 |
0.3 |
GO:0048370 |
lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) |
| 0.3 |
0.6 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.3 |
1.2 |
GO:0033015 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.3 |
1.5 |
GO:0018153 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.3 |
0.9 |
GO:2000627 |
regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
| 0.3 |
2.7 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.3 |
0.9 |
GO:2000395 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.3 |
0.6 |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.3 |
0.9 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 0.3 |
3.0 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.3 |
0.6 |
GO:0045590 |
negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.3 |
1.2 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.3 |
1.2 |
GO:0042262 |
DNA protection(GO:0042262) |
| 0.3 |
0.9 |
GO:0051596 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.3 |
0.9 |
GO:0061312 |
BMP signaling pathway involved in heart development(GO:0061312) |
| 0.3 |
3.2 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.3 |
1.4 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.3 |
1.1 |
GO:0042369 |
vitamin D catabolic process(GO:0042369) |
| 0.3 |
2.0 |
GO:0032383 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.3 |
0.6 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.3 |
1.1 |
GO:0090410 |
malonate catabolic process(GO:0090410) |
| 0.3 |
0.9 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.3 |
2.0 |
GO:0032226 |
positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 0.3 |
0.9 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.3 |
2.0 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.3 |
0.6 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.3 |
0.9 |
GO:0035566 |
vestibulocochlear nerve formation(GO:0021650) regulation of metanephros size(GO:0035566) |
| 0.3 |
2.6 |
GO:0048295 |
positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.3 |
0.9 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.3 |
1.4 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.3 |
6.5 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.3 |
2.3 |
GO:1904386 |
response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 0.3 |
1.1 |
GO:0043418 |
homocysteine catabolic process(GO:0043418) |
| 0.3 |
7.3 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.3 |
0.3 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.3 |
3.4 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.3 |
0.3 |
GO:0071926 |
endocannabinoid signaling pathway(GO:0071926) |
| 0.3 |
0.3 |
GO:0072218 |
ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) |
| 0.3 |
1.1 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.3 |
0.6 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.3 |
1.1 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.3 |
1.7 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.3 |
1.9 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.3 |
1.4 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.3 |
0.8 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.3 |
0.5 |
GO:0044205 |
'de novo' UMP biosynthetic process(GO:0044205) |
| 0.3 |
2.7 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.3 |
0.8 |
GO:0048210 |
Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.3 |
0.5 |
GO:0021707 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.3 |
0.8 |
GO:0071629 |
cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.3 |
0.8 |
GO:0045062 |
extrathymic T cell selection(GO:0045062) |
| 0.3 |
0.3 |
GO:0097237 |
cellular response to toxic substance(GO:0097237) |
| 0.3 |
1.1 |
GO:0060995 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.3 |
0.8 |
GO:0070510 |
regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 0.3 |
1.3 |
GO:0010520 |
regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.3 |
1.1 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.3 |
0.3 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.3 |
1.3 |
GO:0006772 |
thiamine metabolic process(GO:0006772) thiamine diphosphate metabolic process(GO:0042357) |
| 0.3 |
0.5 |
GO:0003285 |
septum secundum development(GO:0003285) |
| 0.3 |
1.0 |
GO:0001188 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.3 |
1.0 |
GO:0060455 |
negative regulation of gastric acid secretion(GO:0060455) |
| 0.3 |
0.3 |
GO:0021515 |
cell differentiation in spinal cord(GO:0021515) |
| 0.3 |
0.3 |
GO:0051415 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.3 |
0.3 |
GO:0009062 |
fatty acid catabolic process(GO:0009062) |
| 0.3 |
0.3 |
GO:0061052 |
negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.3 |
1.3 |
GO:1902228 |
mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 0.3 |
0.8 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 0.3 |
0.8 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.3 |
1.5 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.3 |
1.0 |
GO:1900148 |
Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 0.3 |
1.0 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 0.3 |
0.8 |
GO:0060535 |
trachea cartilage morphogenesis(GO:0060535) |
| 0.3 |
3.3 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
| 0.3 |
2.0 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.3 |
1.0 |
GO:0035669 |
TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.3 |
2.5 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.3 |
5.8 |
GO:0006855 |
drug transmembrane transport(GO:0006855) |
| 0.3 |
2.3 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.2 |
0.7 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.2 |
6.0 |
GO:0016024 |
CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.2 |
1.7 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.2 |
0.7 |
GO:0060829 |
regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.2 |
0.7 |
GO:1905000 |
regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.2 |
2.0 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.2 |
0.5 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.2 |
0.5 |
GO:0035712 |
T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.2 |
2.5 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.2 |
0.7 |
GO:0010159 |
specification of organ position(GO:0010159) |
| 0.2 |
0.2 |
GO:0014839 |
myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.2 |
1.0 |
GO:0031443 |
fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.2 |
3.4 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.2 |
5.6 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.2 |
3.4 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.2 |
1.0 |
GO:0015766 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.2 |
1.0 |
GO:1904106 |
protein localization to microvillus(GO:1904106) |
| 0.2 |
2.7 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.2 |
0.7 |
GO:0035674 |
tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.2 |
0.7 |
GO:0022007 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.2 |
0.2 |
GO:0060823 |
canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.2 |
4.1 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.2 |
0.5 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.2 |
2.1 |
GO:0032310 |
prostaglandin secretion(GO:0032310) |
| 0.2 |
1.9 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.2 |
0.7 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.2 |
0.5 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.2 |
1.9 |
GO:0097461 |
ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.2 |
2.1 |
GO:0009880 |
embryonic pattern specification(GO:0009880) |
| 0.2 |
1.4 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.2 |
0.2 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.2 |
0.2 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.2 |
2.5 |
GO:0046146 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.2 |
4.4 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.2 |
0.5 |
GO:1904031 |
positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.2 |
1.1 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.2 |
1.1 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.2 |
1.1 |
GO:0051292 |
nuclear pore organization(GO:0006999) nuclear pore complex assembly(GO:0051292) |
| 0.2 |
0.7 |
GO:0061580 |
colon epithelial cell migration(GO:0061580) |
| 0.2 |
4.3 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.2 |
1.1 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.2 |
2.2 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.2 |
0.7 |
GO:0016260 |
selenocysteine biosynthetic process(GO:0016260) |
| 0.2 |
1.3 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.2 |
6.0 |
GO:1901663 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.2 |
2.6 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.2 |
1.1 |
GO:0048807 |
female genitalia morphogenesis(GO:0048807) |
| 0.2 |
0.7 |
GO:0046210 |
nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
| 0.2 |
2.4 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.2 |
3.3 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.2 |
1.1 |
GO:0000436 |
carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
| 0.2 |
1.3 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.2 |
0.6 |
GO:0051919 |
positive regulation of fibrinolysis(GO:0051919) |
| 0.2 |
0.2 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.2 |
0.2 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.2 |
0.9 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.2 |
3.6 |
GO:0030202 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.2 |
0.4 |
GO:0015783 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.2 |
1.5 |
GO:0016129 |
phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.2 |
0.8 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.2 |
3.0 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.2 |
0.2 |
GO:0001759 |
organ induction(GO:0001759) embryonic skeletal joint development(GO:0072498) |
| 0.2 |
0.4 |
GO:1904674 |
positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.2 |
0.4 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.2 |
3.6 |
GO:0071397 |
cellular response to cholesterol(GO:0071397) |
| 0.2 |
0.4 |
GO:0001755 |
neural crest cell migration(GO:0001755) |
| 0.2 |
1.5 |
GO:0046104 |
thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.2 |
0.4 |
GO:0043132 |
NAD transport(GO:0043132) |
| 0.2 |
0.2 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.2 |
0.2 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.2 |
0.6 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.2 |
1.8 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.2 |
1.2 |
GO:0032354 |
response to follicle-stimulating hormone(GO:0032354) |
| 0.2 |
1.2 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.2 |
1.0 |
GO:0061074 |
regulation of neural retina development(GO:0061074) |
| 0.2 |
1.8 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.2 |
0.4 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.2 |
0.6 |
GO:0021793 |
chemorepulsion of branchiomotor axon(GO:0021793) |
| 0.2 |
1.2 |
GO:0003062 |
regulation of heart rate by chemical signal(GO:0003062) |
| 0.2 |
1.4 |
GO:0035166 |
post-embryonic hemopoiesis(GO:0035166) |
| 0.2 |
0.8 |
GO:1903803 |
glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.2 |
1.2 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 0.2 |
0.8 |
GO:0071348 |
cellular response to interleukin-11(GO:0071348) |
| 0.2 |
0.6 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.2 |
0.8 |
GO:0006114 |
glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 0.2 |
0.2 |
GO:0060928 |
cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
| 0.2 |
2.1 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.2 |
2.7 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.2 |
0.2 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.2 |
1.3 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.2 |
0.4 |
GO:0033590 |
response to cobalamin(GO:0033590) |
| 0.2 |
0.8 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.2 |
0.4 |
GO:0060809 |
mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.2 |
0.6 |
GO:0032025 |
response to cobalt ion(GO:0032025) |
| 0.2 |
0.8 |
GO:1904779 |
regulation of protein localization to centrosome(GO:1904779) |
| 0.2 |
1.7 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.2 |
0.9 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) |
| 0.2 |
0.9 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.2 |
0.6 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.2 |
0.7 |
GO:0019605 |
butyrate metabolic process(GO:0019605) |
| 0.2 |
1.1 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.2 |
4.3 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.2 |
1.3 |
GO:0071486 |
cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
| 0.2 |
1.1 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.2 |
0.4 |
GO:1902004 |
positive regulation of beta-amyloid formation(GO:1902004) |
| 0.2 |
0.7 |
GO:0015819 |
lysine transport(GO:0015819) L-lysine transport(GO:1902022) L-lysine transmembrane transport(GO:1903401) |
| 0.2 |
0.7 |
GO:0072757 |
cellular response to camptothecin(GO:0072757) |
| 0.2 |
1.5 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.2 |
0.4 |
GO:0098935 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.2 |
2.0 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.2 |
0.2 |
GO:0060431 |
primary lung bud formation(GO:0060431) |
| 0.2 |
0.7 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.2 |
0.9 |
GO:0090341 |
negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.2 |
0.9 |
GO:1901093 |
regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.2 |
0.5 |
GO:0097360 |
Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) Spemann organizer formation(GO:0060061) chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.2 |
1.8 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.2 |
0.2 |
GO:1900127 |
positive regulation of hyaluronan biosynthetic process(GO:1900127) |
| 0.2 |
0.4 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.2 |
1.8 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.2 |
0.5 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 |
1.1 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.2 |
1.6 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.2 |
0.9 |
GO:0051414 |
response to cortisol(GO:0051414) apoptotic process involved in luteolysis(GO:0061364) |
| 0.2 |
0.7 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.2 |
2.5 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.2 |
0.7 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.2 |
0.5 |
GO:0046203 |
spermidine catabolic process(GO:0046203) |
| 0.2 |
0.5 |
GO:0018011 |
N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.2 |
0.7 |
GO:0003016 |
respiratory system process(GO:0003016) |
| 0.2 |
0.9 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.2 |
0.7 |
GO:0046884 |
regulation of follicle-stimulating hormone secretion(GO:0046880) positive regulation of follicle-stimulating hormone secretion(GO:0046881) follicle-stimulating hormone secretion(GO:0046884) |
| 0.2 |
0.3 |
GO:0036034 |
mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.2 |
4.8 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.2 |
1.2 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.2 |
2.2 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.2 |
1.9 |
GO:0006335 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.2 |
1.0 |
GO:0061624 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.2 |
0.9 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.2 |
0.5 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.2 |
1.0 |
GO:0045627 |
positive regulation of T-helper 1 cell differentiation(GO:0045627) |
| 0.2 |
0.7 |
GO:0052026 |
modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.2 |
1.4 |
GO:0036155 |
acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.2 |
3.7 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.2 |
0.5 |
GO:0019516 |
lactate oxidation(GO:0019516) |
| 0.2 |
0.5 |
GO:0032827 |
negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) positive regulation of cytolysis in other organism(GO:0051714) |
| 0.2 |
0.2 |
GO:0031630 |
regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.2 |
1.5 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.2 |
2.3 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.2 |
0.3 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.2 |
0.7 |
GO:0051754 |
meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.2 |
3.8 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.2 |
0.5 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.2 |
0.3 |
GO:2000563 |
positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.2 |
1.2 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.2 |
1.3 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 |
0.2 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.2 |
8.1 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.2 |
2.0 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.2 |
1.0 |
GO:0046075 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.2 |
0.5 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 0.2 |
1.8 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.2 |
2.5 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.2 |
2.5 |
GO:0071816 |
tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.2 |
0.3 |
GO:0002118 |
aggressive behavior(GO:0002118) |
| 0.2 |
0.5 |
GO:0035502 |
metanephric part of ureteric bud development(GO:0035502) |
| 0.2 |
5.7 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.2 |
0.2 |
GO:1990709 |
presynaptic active zone organization(GO:1990709) |
| 0.2 |
1.5 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.2 |
3.7 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.2 |
1.1 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.2 |
1.1 |
GO:2001033 |
negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.2 |
3.8 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.2 |
0.8 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.2 |
1.3 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.2 |
0.2 |
GO:1901620 |
regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
| 0.2 |
0.6 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.2 |
0.5 |
GO:1904924 |
negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.2 |
1.3 |
GO:0060083 |
smooth muscle contraction involved in micturition(GO:0060083) |
| 0.2 |
0.2 |
GO:0072197 |
retinal rod cell differentiation(GO:0060221) ureter morphogenesis(GO:0072197) |
| 0.2 |
0.9 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.2 |
2.7 |
GO:0045636 |
positive regulation of melanocyte differentiation(GO:0045636) |
| 0.2 |
0.2 |
GO:1903799 |
negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.2 |
1.1 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.2 |
0.9 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.2 |
2.8 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.2 |
0.3 |
GO:0006258 |
UDP-glucose catabolic process(GO:0006258) |
| 0.2 |
4.9 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.2 |
0.9 |
GO:0019747 |
regulation of isoprenoid metabolic process(GO:0019747) |
| 0.2 |
0.3 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 0.2 |
0.3 |
GO:0031577 |
spindle checkpoint(GO:0031577) |
| 0.2 |
0.6 |
GO:0035815 |
positive regulation of renal sodium excretion(GO:0035815) |
| 0.2 |
0.8 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.2 |
0.3 |
GO:0070365 |
hepatocyte differentiation(GO:0070365) |
| 0.2 |
1.7 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.2 |
5.0 |
GO:0030207 |
chondroitin sulfate catabolic process(GO:0030207) |
| 0.2 |
0.6 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.2 |
2.0 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.2 |
3.0 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.2 |
0.5 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.2 |
0.3 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.2 |
0.3 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.2 |
0.2 |
GO:0071500 |
cellular response to nitrosative stress(GO:0071500) |
| 0.1 |
1.2 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 |
0.3 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.1 |
0.9 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.1 |
0.6 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.1 |
2.1 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 |
1.8 |
GO:0042532 |
negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.1 |
0.3 |
GO:0060197 |
cloaca development(GO:0035844) cloacal septation(GO:0060197) |
| 0.1 |
2.7 |
GO:0009757 |
hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
| 0.1 |
0.4 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.1 |
0.3 |
GO:0046452 |
dihydrofolate metabolic process(GO:0046452) |
| 0.1 |
0.4 |
GO:2000909 |
regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.1 |
0.4 |
GO:0090182 |
regulation of secretion of lysosomal enzymes(GO:0090182) positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.1 |
0.4 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 |
1.9 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 |
0.3 |
GO:0070256 |
negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.1 |
2.1 |
GO:0070070 |
proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 |
0.6 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 |
0.1 |
GO:0009145 |
purine nucleoside triphosphate biosynthetic process(GO:0009145) |
| 0.1 |
1.8 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.1 |
5.0 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 |
0.3 |
GO:0099565 |
chemical synaptic transmission, postsynaptic(GO:0099565) |
| 0.1 |
1.9 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.1 |
0.4 |
GO:0060345 |
spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
| 0.1 |
2.2 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.1 |
0.4 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 |
0.3 |
GO:0051795 |
positive regulation of catagen(GO:0051795) |
| 0.1 |
2.2 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 |
0.7 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.1 |
2.3 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 |
0.4 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.1 |
0.3 |
GO:0052055 |
modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.1 |
0.1 |
GO:0010430 |
fatty acid omega-oxidation(GO:0010430) |
| 0.1 |
0.4 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 |
1.9 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.1 |
0.4 |
GO:1902568 |
regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.1 |
3.6 |
GO:0060390 |
regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.1 |
0.7 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.1 |
0.4 |
GO:0006425 |
glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.1 |
0.3 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.1 |
0.3 |
GO:0044533 |
induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 0.1 |
0.4 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 |
0.3 |
GO:0032094 |
response to food(GO:0032094) |
| 0.1 |
0.1 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.1 |
1.4 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
2.8 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.1 |
0.1 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.1 |
0.3 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
| 0.1 |
0.8 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 |
0.8 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.1 |
1.2 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.1 |
1.1 |
GO:0071316 |
cellular response to nicotine(GO:0071316) |
| 0.1 |
2.3 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.1 |
1.8 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 |
1.1 |
GO:0055064 |
chloride ion homeostasis(GO:0055064) |
| 0.1 |
0.5 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.1 |
0.4 |
GO:0046356 |
acetyl-CoA catabolic process(GO:0046356) |
| 0.1 |
1.1 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.1 |
0.4 |
GO:0072014 |
proximal tubule development(GO:0072014) |
| 0.1 |
0.4 |
GO:0042450 |
arginine biosynthetic process via ornithine(GO:0042450) |
| 0.1 |
0.4 |
GO:0030821 |
negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.1 |
0.4 |
GO:0070309 |
lens fiber cell morphogenesis(GO:0070309) |
| 0.1 |
2.2 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 |
0.9 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.1 |
0.7 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.1 |
0.4 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 |
0.4 |
GO:2000618 |
regulation of histone H4-K16 acetylation(GO:2000618) |
| 0.1 |
0.5 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 |
0.4 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 |
2.7 |
GO:1990001 |
inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.1 |
0.4 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.1 |
0.7 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 |
2.9 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.1 |
0.4 |
GO:0061217 |
regulation of mesonephros development(GO:0061217) |
| 0.1 |
0.4 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 0.1 |
1.0 |
GO:0050893 |
sensory processing(GO:0050893) |
| 0.1 |
0.3 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.1 |
0.3 |
GO:0030647 |
glycoside metabolic process(GO:0016137) polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.1 |
0.8 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) |
| 0.1 |
0.6 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.6 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.1 |
0.5 |
GO:0045144 |
meiotic sister chromatid segregation(GO:0045144) |
| 0.1 |
2.7 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 |
2.6 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.1 |
1.9 |
GO:1901078 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.1 |
0.8 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.1 |
1.7 |
GO:0070129 |
regulation of mitochondrial translation(GO:0070129) |
| 0.1 |
0.1 |
GO:0090212 |
regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.1 |
0.6 |
GO:0015893 |
drug transport(GO:0015893) |
| 0.1 |
0.5 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 |
1.5 |
GO:1903944 |
regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.1 |
0.6 |
GO:0036511 |
trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.1 |
0.5 |
GO:0098968 |
neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.1 |
0.9 |
GO:1901070 |
guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.1 |
0.4 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.1 |
0.1 |
GO:0035549 |
interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
| 0.1 |
0.9 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.1 |
1.0 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.1 |
1.3 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 |
1.0 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 |
1.7 |
GO:1901978 |
positive regulation of cell cycle checkpoint(GO:1901978) |
| 0.1 |
0.6 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 |
2.5 |
GO:0031163 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
1.6 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.1 |
0.7 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.1 |
1.3 |
GO:0046322 |
negative regulation of fatty acid oxidation(GO:0046322) |
| 0.1 |
0.2 |
GO:1904204 |
regulation of skeletal muscle hypertrophy(GO:1904204) |
| 0.1 |
0.2 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 |
1.6 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 |
0.6 |
GO:0002155 |
regulation of thyroid hormone mediated signaling pathway(GO:0002155) kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.1 |
0.6 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.1 |
0.5 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.1 |
0.4 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.1 |
0.1 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.1 |
0.9 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.1 |
1.1 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
| 0.1 |
0.2 |
GO:0000454 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.1 |
0.1 |
GO:1900449 |
regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.1 |
1.6 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.1 |
0.2 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.1 |
1.0 |
GO:0014037 |
Schwann cell differentiation(GO:0014037) |
| 0.1 |
1.6 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.1 |
1.0 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.1 |
0.7 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.1 |
0.5 |
GO:0045208 |
MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.1 |
0.7 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.1 |
0.4 |
GO:0032661 |
regulation of interleukin-18 production(GO:0032661) interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
| 0.1 |
0.9 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 |
0.6 |
GO:1901073 |
N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.1 |
0.5 |
GO:2000836 |
androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
| 0.1 |
0.2 |
GO:0010002 |
cardioblast differentiation(GO:0010002) |
| 0.1 |
0.9 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.1 |
0.9 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.1 |
0.7 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.1 |
2.3 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.1 |
2.1 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 0.1 |
2.9 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.1 |
0.2 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 |
0.3 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.1 |
0.6 |
GO:0019303 |
D-ribose metabolic process(GO:0006014) D-ribose catabolic process(GO:0019303) |
| 0.1 |
0.2 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.1 |
0.3 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.1 |
2.5 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
0.5 |
GO:0044211 |
CTP salvage(GO:0044211) |
| 0.1 |
2.5 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.1 |
0.9 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.1 |
0.5 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.1 |
0.9 |
GO:0046185 |
aldehyde catabolic process(GO:0046185) |
| 0.1 |
0.3 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.1 |
4.9 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.1 |
1.7 |
GO:0010990 |
regulation of SMAD protein complex assembly(GO:0010990) |
| 0.1 |
0.2 |
GO:0002424 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
| 0.1 |
0.9 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.1 |
1.0 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.1 |
0.1 |
GO:0070197 |
meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.1 |
0.5 |
GO:0019373 |
epoxygenase P450 pathway(GO:0019373) |
| 0.1 |
0.8 |
GO:0043606 |
histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.1 |
1.4 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.1 |
0.7 |
GO:0016321 |
female meiosis chromosome segregation(GO:0016321) |
| 0.1 |
1.2 |
GO:0010993 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.1 |
0.3 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
| 0.1 |
1.6 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.1 |
0.7 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 |
0.7 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.1 |
0.9 |
GO:0034134 |
toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.1 |
0.1 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.1 |
0.1 |
GO:0072179 |
nephric duct formation(GO:0072179) |
| 0.1 |
1.1 |
GO:0097338 |
response to clozapine(GO:0097338) |
| 0.1 |
0.1 |
GO:0051350 |
negative regulation of lyase activity(GO:0051350) |
| 0.1 |
0.7 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 0.1 |
1.4 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.1 |
0.4 |
GO:0035624 |
receptor transactivation(GO:0035624) |
| 0.1 |
0.1 |
GO:0000961 |
negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.1 |
0.3 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.1 |
0.1 |
GO:0045408 |
regulation of interleukin-6 biosynthetic process(GO:0045408) |
| 0.1 |
0.4 |
GO:0042374 |
phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.1 |
0.2 |
GO:2000259 |
positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.1 |
0.7 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 |
0.1 |
GO:0090296 |
regulation of mitochondrial DNA replication(GO:0090296) |
| 0.1 |
0.2 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.1 |
0.8 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.1 |
0.2 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 |
0.3 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.1 |
3.0 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.1 |
0.4 |
GO:0016267 |
O-glycan processing, core 1(GO:0016267) |
| 0.1 |
0.2 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.1 |
0.8 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.1 |
0.4 |
GO:0040023 |
nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
| 0.1 |
0.2 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
| 0.1 |
0.1 |
GO:0006844 |
acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.1 |
0.5 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.1 |
0.4 |
GO:0052651 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.1 |
2.4 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.1 |
0.5 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.1 |
0.6 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.1 |
11.8 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.1 |
0.3 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.1 |
0.4 |
GO:0006500 |
N-terminal protein palmitoylation(GO:0006500) |
| 0.1 |
0.4 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.1 |
1.3 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.1 |
0.3 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.1 |
0.3 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.1 |
1.1 |
GO:0098659 |
sodium ion import(GO:0097369) inorganic cation import into cell(GO:0098659) sodium ion import across plasma membrane(GO:0098719) inorganic ion import into cell(GO:0099587) sodium ion import into cell(GO:1990118) |
| 0.1 |
0.5 |
GO:1902775 |
mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 |
0.4 |
GO:0071462 |
cellular response to water stimulus(GO:0071462) |
| 0.1 |
0.2 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) peptidyl-glutamic acid modification(GO:0018200) protein carboxylation(GO:0018214) |
| 0.1 |
0.9 |
GO:0097396 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 |
0.6 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.1 |
GO:1901420 |
negative regulation of vitamin D receptor signaling pathway(GO:0070563) negative regulation of response to alcohol(GO:1901420) |
| 0.1 |
0.1 |
GO:0046619 |
optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
| 0.1 |
3.0 |
GO:0071173 |
mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
| 0.1 |
1.3 |
GO:0072311 |
glomerular epithelial cell differentiation(GO:0072311) |
| 0.1 |
0.3 |
GO:0021997 |
neural plate axis specification(GO:0021997) |
| 0.1 |
0.7 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.1 |
3.7 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.1 |
0.4 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.1 |
0.8 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.1 |
0.6 |
GO:0086021 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.1 |
0.6 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.1 |
0.3 |
GO:0044727 |
DNA demethylation of male pronucleus(GO:0044727) |
| 0.1 |
0.4 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.1 |
0.5 |
GO:0036496 |
regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.1 |
0.7 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.1 |
0.8 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.1 |
0.5 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.1 |
2.5 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 |
1.4 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
0.1 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.1 |
0.4 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.1 |
0.1 |
GO:0071469 |
response to alkaline pH(GO:0010446) cellular response to alkaline pH(GO:0071469) |
| 0.1 |
0.5 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.1 |
1.2 |
GO:0003310 |
pancreatic A cell differentiation(GO:0003310) |
| 0.1 |
0.5 |
GO:1904636 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.1 |
0.6 |
GO:0019542 |
acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.1 |
0.4 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.1 |
1.1 |
GO:0050766 |
positive regulation of phagocytosis(GO:0050766) |
| 0.1 |
0.5 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.1 |
1.2 |
GO:0050961 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.1 |
0.5 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.1 |
0.2 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.1 |
0.6 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.1 |
1.2 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 |
0.4 |
GO:0086017 |
Purkinje myocyte action potential(GO:0086017) membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 0.1 |
3.8 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.1 |
3.0 |
GO:0009214 |
cyclic nucleotide catabolic process(GO:0009214) |
| 0.1 |
1.1 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
0.3 |
GO:0044065 |
regulation of respiratory system process(GO:0044065) |
| 0.1 |
0.1 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.1 |
0.2 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.1 |
0.5 |
GO:0070370 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.1 |
1.3 |
GO:2000615 |
regulation of histone H3-K9 acetylation(GO:2000615) |
| 0.1 |
1.6 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.1 |
0.2 |
GO:0071379 |
cellular response to prostaglandin stimulus(GO:0071379) |
| 0.1 |
0.2 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.1 |
0.8 |
GO:0015827 |
tryptophan transport(GO:0015827) |
| 0.1 |
5.8 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.1 |
2.1 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 0.1 |
3.2 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.1 |
0.3 |
GO:0042816 |
vitamin B6 metabolic process(GO:0042816) |
| 0.1 |
0.9 |
GO:0006782 |
protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.1 |
1.1 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.1 |
0.7 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 0.1 |
0.2 |
GO:0032096 |
regulation of response to food(GO:0032095) negative regulation of response to food(GO:0032096) regulation of appetite(GO:0032098) negative regulation of appetite(GO:0032099) |
| 0.1 |
0.9 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 |
1.2 |
GO:0036109 |
alpha-linolenic acid metabolic process(GO:0036109) |
| 0.1 |
1.9 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 |
0.2 |
GO:1902969 |
mitotic DNA replication(GO:1902969) |
| 0.1 |
1.0 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.1 |
0.7 |
GO:2001044 |
regulation of integrin-mediated signaling pathway(GO:2001044) |
| 0.1 |
0.2 |
GO:0006288 |
base-excision repair, DNA ligation(GO:0006288) regulation of DNA ligase activity(GO:1904875) |
| 0.1 |
0.8 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.1 |
1.4 |
GO:0009437 |
carnitine metabolic process(GO:0009437) |
| 0.1 |
2.5 |
GO:0047497 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.1 |
0.8 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 0.1 |
0.3 |
GO:0070943 |
neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
| 0.1 |
0.1 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
6.1 |
GO:0007077 |
mitotic nuclear envelope disassembly(GO:0007077) |
| 0.1 |
0.2 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.1 |
0.3 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.1 |
0.4 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.1 |
1.0 |
GO:0032411 |
positive regulation of transporter activity(GO:0032411) |
| 0.1 |
0.7 |
GO:1902916 |
positive regulation of protein polyubiquitination(GO:1902916) |
| 0.1 |
0.2 |
GO:0042135 |
neurotransmitter catabolic process(GO:0042135) |
| 0.1 |
0.4 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.1 |
4.7 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.1 |
3.3 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.1 |
1.7 |
GO:0051383 |
kinetochore organization(GO:0051383) |
| 0.1 |
0.5 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.1 |
0.2 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
1.1 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.1 |
0.1 |
GO:0014052 |
regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.1 |
0.2 |
GO:1904849 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.1 |
0.7 |
GO:0046475 |
glycerophospholipid catabolic process(GO:0046475) |
| 0.1 |
0.2 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.1 |
0.4 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.1 |
0.4 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.1 |
0.2 |
GO:0035932 |
mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
| 0.1 |
0.3 |
GO:0010960 |
magnesium ion homeostasis(GO:0010960) |
| 0.1 |
0.5 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.1 |
0.3 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.1 |
1.5 |
GO:2001046 |
positive regulation of integrin-mediated signaling pathway(GO:2001046) |
| 0.1 |
0.5 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.1 |
0.3 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 |
0.5 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
0.2 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.1 |
1.1 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.1 |
0.3 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.1 |
0.1 |
GO:1904815 |
negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
| 0.1 |
0.2 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.1 |
0.4 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.1 |
1.1 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 |
2.5 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.1 |
0.7 |
GO:0060313 |
negative regulation of blood vessel remodeling(GO:0060313) |
| 0.1 |
0.3 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.1 |
0.2 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 |
0.1 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.1 |
0.4 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.1 |
0.1 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.1 |
0.3 |
GO:0019471 |
4-hydroxyproline metabolic process(GO:0019471) |
| 0.1 |
0.3 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.1 |
1.0 |
GO:0021895 |
cerebral cortex neuron differentiation(GO:0021895) |
| 0.1 |
0.4 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.1 |
6.8 |
GO:0051436 |
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) |
| 0.1 |
0.4 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 |
0.9 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 |
0.4 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.1 |
0.2 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.1 |
0.9 |
GO:0006554 |
lysine catabolic process(GO:0006554) |
| 0.1 |
0.2 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 |
0.3 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
0.3 |
GO:0060600 |
dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
| 0.1 |
0.3 |
GO:1902590 |
viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
| 0.1 |
0.3 |
GO:0070845 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.1 |
0.5 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.1 |
0.1 |
GO:0002316 |
follicular B cell differentiation(GO:0002316) |
| 0.1 |
0.1 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.1 |
0.7 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.1 |
0.9 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
0.3 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.1 |
0.3 |
GO:0061303 |
cornea development in camera-type eye(GO:0061303) |
| 0.1 |
0.3 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 |
0.2 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.1 |
0.7 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.1 |
0.6 |
GO:0036149 |
phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.1 |
0.3 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.1 |
0.2 |
GO:0060381 |
regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.1 |
0.1 |
GO:0061009 |
common bile duct development(GO:0061009) |
| 0.1 |
0.1 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.1 |
0.9 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) |
| 0.1 |
0.5 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 |
0.1 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.1 |
1.1 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 |
0.3 |
GO:0018277 |
protein deamination(GO:0018277) |
| 0.1 |
0.2 |
GO:0001579 |
medium-chain fatty acid transport(GO:0001579) |
| 0.1 |
0.5 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 |
0.4 |
GO:0098746 |
fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.1 |
0.2 |
GO:0006043 |
glucosamine catabolic process(GO:0006043) |
| 0.1 |
2.5 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.1 |
0.3 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.1 |
1.1 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.1 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.1 |
0.3 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 |
0.1 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.1 |
0.5 |
GO:0098989 |
NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.1 |
0.8 |
GO:0051969 |
regulation of transmission of nerve impulse(GO:0051969) |
| 0.1 |
0.5 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.8 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 |
1.1 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) |
| 0.1 |
0.2 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.1 |
0.1 |
GO:0006550 |
isoleucine catabolic process(GO:0006550) |
| 0.1 |
0.2 |
GO:0010133 |
proline catabolic process to glutamate(GO:0010133) |
| 0.1 |
0.1 |
GO:0072674 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.1 |
0.1 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
| 0.1 |
0.4 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 |
0.9 |
GO:1901642 |
nucleoside transmembrane transport(GO:1901642) |
| 0.1 |
0.2 |
GO:2001303 |
lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 0.1 |
0.2 |
GO:0070431 |
nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.1 |
0.2 |
GO:1902728 |
positive regulation of skeletal muscle cell proliferation(GO:0014858) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 0.1 |
0.7 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.1 |
0.2 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
0.1 |
GO:0032304 |
negative regulation of icosanoid secretion(GO:0032304) |
| 0.1 |
0.3 |
GO:0034128 |
negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.1 |
0.6 |
GO:0006069 |
ethanol oxidation(GO:0006069) |
| 0.1 |
0.2 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.1 |
0.1 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.1 |
1.4 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.1 |
0.3 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.1 |
0.2 |
GO:0046098 |
guanine metabolic process(GO:0046098) |
| 0.1 |
0.6 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.1 |
0.2 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 0.1 |
0.2 |
GO:0007442 |
hindgut morphogenesis(GO:0007442) |
| 0.1 |
0.2 |
GO:0045415 |
negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
| 0.1 |
0.1 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.1 |
0.2 |
GO:0033058 |
directional locomotion(GO:0033058) |
| 0.1 |
0.2 |
GO:0003335 |
corneocyte development(GO:0003335) |
| 0.1 |
0.4 |
GO:0060526 |
prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.1 |
5.2 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.1 |
0.5 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.3 |
GO:0035633 |
maintenance of blood-brain barrier(GO:0035633) chemokine (C-C motif) ligand 2 secretion(GO:0035926) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.1 |
4.7 |
GO:0097031 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 |
1.1 |
GO:0010824 |
regulation of centrosome duplication(GO:0010824) |
| 0.1 |
0.2 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 0.1 |
0.5 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 |
0.1 |
GO:0007227 |
signal transduction downstream of smoothened(GO:0007227) |
| 0.1 |
0.1 |
GO:0019374 |
galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
| 0.1 |
0.1 |
GO:0036146 |
cellular response to mycotoxin(GO:0036146) |
| 0.1 |
0.3 |
GO:0007494 |
midgut development(GO:0007494) |
| 0.1 |
2.1 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 |
0.2 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.1 |
0.2 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
| 0.1 |
0.8 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.1 |
1.6 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 |
0.4 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.0 |
0.1 |
GO:1903567 |
negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.0 |
0.1 |
GO:0008589 |
regulation of smoothened signaling pathway(GO:0008589) |
| 0.0 |
0.1 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.0 |
0.1 |
GO:0070253 |
somatostatin secretion(GO:0070253) |
| 0.0 |
2.6 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.0 |
0.2 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.0 |
0.2 |
GO:0044108 |
calcitriol biosynthetic process from calciol(GO:0036378) cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
| 0.0 |
0.1 |
GO:0010637 |
regulation of mitochondrial fusion(GO:0010635) negative regulation of mitochondrial fusion(GO:0010637) |
| 0.0 |
0.2 |
GO:0042144 |
vacuole fusion, non-autophagic(GO:0042144) |
| 0.0 |
0.1 |
GO:0010644 |
cell communication by electrical coupling(GO:0010644) |
| 0.0 |
0.6 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.0 |
0.9 |
GO:0007091 |
metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
| 0.0 |
0.2 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.0 |
0.7 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.0 |
3.4 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.0 |
0.6 |
GO:0098870 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.0 |
1.9 |
GO:0007271 |
synaptic transmission, cholinergic(GO:0007271) |
| 0.0 |
0.1 |
GO:2000317 |
negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.0 |
0.2 |
GO:0015785 |
UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.0 |
1.1 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.0 |
2.5 |
GO:0032480 |
negative regulation of type I interferon production(GO:0032480) |
| 0.0 |
0.4 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.0 |
0.5 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.0 |
0.6 |
GO:0002455 |
humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
| 0.0 |
0.1 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 |
0.2 |
GO:1901386 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.0 |
0.6 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.0 |
0.4 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.0 |
0.1 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 0.0 |
0.4 |
GO:0006734 |
NADH metabolic process(GO:0006734) |
| 0.0 |
0.1 |
GO:0035864 |
response to potassium ion(GO:0035864) |
| 0.0 |
0.1 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.0 |
0.1 |
GO:0071332 |
positive regulation of vascular wound healing(GO:0035470) epithelial cell differentiation involved in salivary gland development(GO:0060690) epithelial cell maturation involved in salivary gland development(GO:0060691) cellular response to fructose stimulus(GO:0071332) regulation of plasma cell differentiation(GO:1900098) positive regulation of plasma cell differentiation(GO:1900100) regulation of lactation(GO:1903487) positive regulation of lactation(GO:1903489) |
| 0.0 |
0.4 |
GO:1901660 |
calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.0 |
0.2 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.0 |
0.3 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.0 |
0.4 |
GO:0044803 |
multi-organism membrane organization(GO:0044803) |
| 0.0 |
0.1 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.0 |
0.9 |
GO:0060445 |
branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.0 |
0.2 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.0 |
0.4 |
GO:0045840 |
positive regulation of mitotic nuclear division(GO:0045840) |
| 0.0 |
0.9 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.0 |
0.1 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.0 |
0.7 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 |
0.6 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.0 |
0.1 |
GO:0031629 |
synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.0 |
0.4 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.0 |
0.2 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.2 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.0 |
0.8 |
GO:0006032 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 |
0.1 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.0 |
0.2 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.0 |
0.0 |
GO:0055089 |
fatty acid homeostasis(GO:0055089) |
| 0.0 |
0.6 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.0 |
0.6 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.0 |
0.3 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.0 |
0.1 |
GO:1904586 |
response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
| 0.0 |
0.2 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.0 |
0.1 |
GO:0051792 |
medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.0 |
0.8 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.0 |
0.2 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.0 |
0.1 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.0 |
0.2 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.0 |
3.2 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 |
0.5 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.0 |
0.3 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.0 |
0.1 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.0 |
0.2 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.0 |
0.2 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.0 |
0.3 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.0 |
0.1 |
GO:0070901 |
mitochondrial tRNA methylation(GO:0070901) |
| 0.0 |
3.3 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.1 |
GO:0046725 |
negative regulation by virus of viral protein levels in host cell(GO:0046725) kidney mesenchymal cell proliferation(GO:0072135) metanephric mesenchymal cell proliferation involved in metanephros development(GO:0072136) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
| 0.0 |
0.3 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.0 |
0.1 |
GO:0006826 |
iron ion transport(GO:0006826) |
| 0.0 |
1.4 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.0 |
0.3 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 |
0.1 |
GO:0072240 |
distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric DCT cell differentiation(GO:0072240) metanephric nephron tubule formation(GO:0072289) |
| 0.0 |
0.1 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.0 |
0.4 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.0 |
0.1 |
GO:0031110 |
regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.0 |
0.2 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 |
0.4 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.0 |
0.1 |
GO:0001708 |
cell fate specification(GO:0001708) |
| 0.0 |
0.3 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.0 |
0.8 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.0 |
0.0 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) |
| 0.0 |
0.0 |
GO:1904862 |
inhibitory synapse assembly(GO:1904862) |
| 0.0 |
0.1 |
GO:0014866 |
skeletal myofibril assembly(GO:0014866) |
| 0.0 |
0.2 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.0 |
0.8 |
GO:0048566 |
embryonic digestive tract development(GO:0048566) |
| 0.0 |
0.4 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.0 |
0.2 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.0 |
0.1 |
GO:1904530 |
regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
| 0.0 |
0.4 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.0 |
0.0 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.0 |
0.1 |
GO:1903677 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.0 |
0.0 |
GO:2000721 |
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.0 |
1.2 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 |
0.1 |
GO:0002636 |
positive regulation of germinal center formation(GO:0002636) |
| 0.0 |
0.1 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.0 |
0.1 |
GO:0033320 |
UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.0 |
0.1 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.0 |
0.4 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.0 |
1.0 |
GO:0046856 |
phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 |
0.1 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.0 |
1.0 |
GO:0051298 |
centrosome duplication(GO:0051298) |
| 0.0 |
0.3 |
GO:0001964 |
startle response(GO:0001964) |
| 0.0 |
2.3 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.0 |
0.1 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.0 |
4.3 |
GO:0045047 |
protein targeting to ER(GO:0045047) |
| 0.0 |
0.1 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.0 |
0.3 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.0 |
0.3 |
GO:0046325 |
negative regulation of glucose import(GO:0046325) |
| 0.0 |
0.2 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.0 |
0.0 |
GO:0051573 |
negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.0 |
0.1 |
GO:0035630 |
bone mineralization involved in bone maturation(GO:0035630) |
| 0.0 |
0.1 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.0 |
0.1 |
GO:0002911 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.0 |
0.4 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 |
0.7 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.0 |
0.2 |
GO:0043555 |
regulation of translation in response to stress(GO:0043555) |
| 0.0 |
0.1 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.0 |
0.1 |
GO:0000730 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.0 |
0.2 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 |
0.1 |
GO:0090156 |
cellular sphingolipid homeostasis(GO:0090156) |
| 0.0 |
0.1 |
GO:0035553 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.0 |
0.3 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.0 |
0.1 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
| 0.0 |
0.3 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.0 |
0.2 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.0 |
0.2 |
GO:1904816 |
positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.0 |
0.0 |
GO:0051495 |
positive regulation of cytoskeleton organization(GO:0051495) |
| 0.0 |
0.2 |
GO:1904872 |
regulation of telomerase RNA localization to Cajal body(GO:1904872) |
| 0.0 |
0.3 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.0 |
0.4 |
GO:0001773 |
myeloid dendritic cell activation(GO:0001773) myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 |
0.1 |
GO:0099624 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.0 |
0.3 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.0 |
0.1 |
GO:0098581 |
detection of external biotic stimulus(GO:0098581) |
| 0.0 |
0.1 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.0 |
0.4 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 |
0.1 |
GO:0046457 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.0 |
0.5 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 |
0.1 |
GO:0034104 |
negative regulation of tissue remodeling(GO:0034104) |
| 0.0 |
0.1 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.0 |
0.2 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
0.1 |
GO:0051685 |
maintenance of ER location(GO:0051685) |
| 0.0 |
0.1 |
GO:0010663 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.0 |
0.0 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.0 |
0.1 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.0 |
0.3 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.0 |
0.1 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.0 |
0.3 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.0 |
0.3 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.0 |
0.5 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.0 |
0.1 |
GO:1902993 |
positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
| 0.0 |
0.1 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.0 |
0.8 |
GO:0045739 |
positive regulation of DNA repair(GO:0045739) |
| 0.0 |
0.1 |
GO:0048382 |
mesendoderm development(GO:0048382) |
| 0.0 |
0.1 |
GO:0071360 |
cellular response to exogenous dsRNA(GO:0071360) |
| 0.0 |
0.9 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.0 |
1.0 |
GO:0050982 |
detection of mechanical stimulus(GO:0050982) |
| 0.0 |
0.2 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.0 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.0 |
0.1 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.0 |
0.2 |
GO:1903818 |
positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.0 |
0.1 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.0 |
0.1 |
GO:0006768 |
biotin metabolic process(GO:0006768) |
| 0.0 |
0.5 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
0.1 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.0 |
0.1 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.0 |
0.4 |
GO:0043562 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 |
0.1 |
GO:0051572 |
negative regulation of histone H3-K4 methylation(GO:0051572) |
| 0.0 |
0.6 |
GO:0007131 |
reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.0 |
1.3 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.0 |
0.4 |
GO:0045646 |
regulation of erythrocyte differentiation(GO:0045646) |
| 0.0 |
0.0 |
GO:0051788 |
response to misfolded protein(GO:0051788) |
| 0.0 |
0.1 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.0 |
0.1 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.0 |
0.2 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.0 |
0.0 |
GO:0048485 |
sympathetic nervous system development(GO:0048485) |
| 0.0 |
0.1 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.0 |
0.1 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.0 |
0.4 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.0 |
0.1 |
GO:0007200 |
phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.0 |
0.1 |
GO:0017004 |
cytochrome complex assembly(GO:0017004) |
| 0.0 |
0.4 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.0 |
0.3 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.0 |
0.1 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.0 |
0.1 |
GO:0046946 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.0 |
1.6 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.0 |
0.2 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.0 |
0.1 |
GO:2000535 |
regulation of entry of bacterium into host cell(GO:2000535) |
| 0.0 |
0.2 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
0.1 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.0 |
0.1 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.0 |
0.5 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.0 |
0.1 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.0 |
0.5 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.0 |
0.4 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.0 |
0.0 |
GO:0051195 |
negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.0 |
0.1 |
GO:0021772 |
olfactory bulb development(GO:0021772) |
| 0.0 |
0.1 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.0 |
0.1 |
GO:0032610 |
interleukin-1 alpha production(GO:0032610) interleukin-1 alpha secretion(GO:0050703) |
| 0.0 |
0.1 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.0 |
0.1 |
GO:0033687 |
osteoblast proliferation(GO:0033687) |
| 0.0 |
0.3 |
GO:0014904 |
myotube cell development(GO:0014904) |
| 0.0 |
0.3 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.0 |
0.2 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.0 |
0.0 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.0 |
0.1 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.0 |
0.2 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.0 |
0.3 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
0.0 |
GO:0046603 |
negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.0 |
0.1 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.0 |
0.5 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.0 |
0.3 |
GO:1902307 |
positive regulation of sodium ion transmembrane transport(GO:1902307) |
| 0.0 |
0.0 |
GO:2000389 |
regulation of neutrophil extravasation(GO:2000389) |
| 0.0 |
0.1 |
GO:0007501 |
mesodermal cell fate specification(GO:0007501) |
| 0.0 |
0.2 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.0 |
GO:0050917 |
sensory perception of umami taste(GO:0050917) |
| 0.0 |
0.1 |
GO:0072348 |
sulfur compound transport(GO:0072348) |
| 0.0 |
0.2 |
GO:0071320 |
cellular response to cAMP(GO:0071320) |
| 0.0 |
0.0 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 0.0 |
0.0 |
GO:0072708 |
response to sorbitol(GO:0072708) |
| 0.0 |
0.2 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.0 |
0.1 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.0 |
0.0 |
GO:0071586 |
CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.0 |
0.4 |
GO:0032878 |
regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.0 |
0.0 |
GO:1901074 |
regulation of engulfment of apoptotic cell(GO:1901074) positive regulation of engulfment of apoptotic cell(GO:1901076) regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 0.0 |
0.0 |
GO:0097327 |
response to antineoplastic agent(GO:0097327) |
| 0.0 |
0.1 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.0 |
0.1 |
GO:0050712 |
negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.0 |
0.0 |
GO:0070296 |
sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.0 |
0.1 |
GO:0043126 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.0 |
0.2 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.0 |
0.4 |
GO:0043574 |
peroxisomal transport(GO:0043574) |
| 0.0 |
0.1 |
GO:0014854 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) |
| 0.0 |
0.1 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.0 |
0.0 |
GO:0038170 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.0 |
0.1 |
GO:0071799 |
response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.0 |
0.3 |
GO:0010862 |
positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.0 |
0.3 |
GO:0051560 |
mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.0 |
0.4 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.0 |
0.2 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 |
0.3 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.1 |
GO:0017185 |
peptidyl-lysine hydroxylation(GO:0017185) |
| 0.0 |
0.1 |
GO:0060312 |
regulation of blood vessel remodeling(GO:0060312) |
| 0.0 |
0.1 |
GO:0021615 |
glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 |
0.1 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.0 |
0.0 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.0 |
0.1 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.0 |
0.1 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.0 |
0.0 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.0 |
0.1 |
GO:0002827 |
positive regulation of T-helper 1 type immune response(GO:0002827) |
| 0.0 |
0.0 |
GO:0032727 |
positive regulation of interferon-alpha production(GO:0032727) |
| 0.0 |
0.2 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.0 |
0.1 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.0 |
0.1 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.0 |
0.1 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
